Osimertinib versus Durvalumab versus observation after chemoradiation in unresectable EGFR-mutant NSCLC - Zhao, Binghao; Yao, Longping; Ma, Wenbin (Journal of thoracic oncology, 2024)
Online verfügbar: 6. Mai 2024
Gesehen am 25.11.2024